Feng Chi Biotech Corp. (6744.TWO)
TWD 19.7
(0.0%)
TWD 19.7
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 24.16 Million TWD | -9.36% |
| 2022 | 30.47 Million TWD | 8.24% |
| 2021 | 28.15 Million TWD | -6.12% |
| 2020 | 29.99 Million TWD | 49.23% |
| 2019 | 20.09 Million TWD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 5.52 Million TWD | 0.0% |
| 2024 Q1 | 5.52 Million TWD | 23.95% |
| 2023 Q4 | 4.45 Million TWD | 0.0% |
| 2023 FY | 27.62 Million TWD | -9.36% |
| 2023 Q3 | 4.45 Million TWD | -41.58% |
| 2023 Q2 | 7.62 Million TWD | 0.0% |
| 2023 Q1 | 7.62 Million TWD | 34.57% |
| 2022 Q4 | 5.66 Million TWD | 0.0% |
| 2022 FY | 30.47 Million TWD | 8.24% |
| 2022 Q3 | 5.66 Million TWD | 0.0% |
| 2021 FY | 28.15 Million TWD | -6.12% |
| 2020 FY | 29.99 Million TWD | 49.23% |
| 2019 FY | 20.09 Million TWD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Bio Preventive Medicine Corp. | -70.58 Million TWD | 134.233% |
| Genomics BioSci & Tech. Co.,Ltd. | -84.99 Million TWD | 128.428% |
| Advagene Biopharma Co., Ltd. | -93.33 Million TWD | 125.887% |
| Taiwan Bio Therapeutics Co., Ltd | -212.2 Million TWD | 111.386% |
| NaviFUS Corp. | -76.42 Million TWD | 131.615% |
| G&E Herbal Biotechnology Co., Ltd. | 80.68 Million TWD | 70.054% |
| TaiRx, Inc. | -214.69 Million TWD | 111.254% |
| Sinew Pharma Inc. | -186.25 Million TWD | 112.973% |
| Lin BioScience, Inc. | -1.09 Billion TWD | 102.203% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.61 Million TWD | 465.537% |
| Lumosa Therapeutics Co., Ltd. | -375.62 Million TWD | 106.432% |
| Anti-Microbial Savior BioteQ Co., Ltd | -56.74 Million TWD | 142.577% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 281.85 Million TWD | 91.427% |
| AP Biosciences Inc | -347.47 Million TWD | 106.954% |
| Sunmax Biotechnology Co., Ltd. | 894.79 Million TWD | 97.3% |
| RBC Bioscience Corporation | 14.53 Million TWD | -66.187% |
| Syngen Biotech Co.,Ltd. | 334.08 Million TWD | 92.768% |
| EirGenix Inc. | -1.03 Billion TWD | 102.341% |
| Enimmune corporation | -243.47 Million TWD | 109.924% |
| Lukas Biomedical Inc. | -43.56 Million TWD | 155.468% |
| BRIM Biotechnology, Inc. | -694.12 Million TWD | 103.481% |
| 3D Global Biotech Inc. | -62.85 Million TWD | 138.442% |
| TaiMed Biologics Inc. | -166.23 Million TWD | 114.535% |
| Mycenax Biotech Inc. | -602.1 Million TWD | 104.013% |
| TCI GENE Inc. | 10.04 Million TWD | -140.442% |
| SynCore Biotechnology Co.,Ltd | -45.5 Million TWD | 153.101% |
| Oneness Biotech Co., Ltd. | -1.09 Billion TWD | 102.203% |
| Eusol Biotech Co.,Ltd. | -41.48 Million TWD | 158.247% |
| NeoCore Technology Co., Ltd. | -84.94 Million TWD | 128.445% |
| TWi Biotechnology, Inc. | -169.55 Million TWD | 114.25% |
| Neith Corporation | -48.85 Million TWD | 149.458% |
| Sunny Pharmtech Inc. | -72.09 Million TWD | 133.514% |
| VBI | -16.13 Million TWD | 249.777% |
| Ever Supreme Bio Technology Co., Ltd | 337.73 Million TWD | 92.846% |
| GeneReach Biotechnology Corp. | -229.28 Million TWD | 110.538% |
| Shine-On BioMedical Co.,Ltd. | -62.68 Million TWD | 138.546% |
| CHO Pharma, Inc. | -268.99 Million TWD | 108.982% |
| Andros Pharmaceuticals Co.,Ltd | -67.69 Million TWD | 135.691% |
| MegaPro Biomedical Co., Ltd | -127.25 Million TWD | 118.987% |
| Visgeneer Inc. | -21.15 Million TWD | 214.193% |
| Greenyn Biotechnology Co., Ltd | 159.81 Million TWD | 84.881% |
| BioLASCO Taiwan Co., Ltd. | 63.33 Million TWD | 61.85% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -93.95 Million TWD | 125.717% |
| Sagittarius Life Science Corp | -64.37 Million TWD | 137.533% |
| BioGend Therapeutics Co., Ltd. | -176.54 Million TWD | 113.686% |
| GlycoNex Incorporation | -259.86 Million TWD | 109.298% |
| Medigen Biotechnology Corp. | -1.23 Billion TWD | 101.959% |
| Pharmosa Biopharm Inc. | -2.82 Million TWD | 955.595% |
| PharmaEngine, Inc. | 277.18 Million TWD | 91.283% |
| Intech Biopharm Corporation | -304.39 Million TWD | 107.938% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -2.25 Million TWD | 1172.437% |
| BiOptic Inc. | 44.05 Million TWD | 45.152% |
| TaiGen Biopharmaceuticals Holdings Limited | -174.69 Million TWD | 113.831% |
| Senhwa Biosciences, Inc. | -311.11 Million TWD | 107.766% |
| NatureWise Biotech & Medicals Corporation | 3.43 Million TWD | -603.611% |
| OBI Pharma, Inc. | -2.08 Billion TWD | 101.156% |
| Savior Lifetec Corporation | -2.42 Million TWD | 1098.43% |
| Great Novel Therapeutics Biotech & Medicals | -65.81 Million TWD | 136.709% |
| Level Biotechnology Inc. | 67.55 Million TWD | 64.232% |
| Medigen Vaccine Biologics Corporation | -1.21 Billion TWD | 101.991% |
| Meribank Biotech Co., Ltd | -123.15 Million TWD | 119.619% |
| Acepodia, Inc. | -435.97 Million TWD | 105.542% |
| Caliway Biopharmaceuticals Co., Ltd. | -487.95 Million TWD | 104.952% |